MDMAPharmala Biotech HoldingsMDMA info
$0.06info0.00%24h
Global rank34673
Market cap$4.67M
Change 7d-16.67%
YTD Performance-48.28%
SP500 benchmarkUnderperform
P/E-5.53
P/S11.92
Revenue$392.16K
Earnings-$574.83K
Dividend yield-
Main Sector
Healthcare

Pharmala Biotech Holdings (MDMA) Net Assets

MDMA Net Assets in 2023: $1.38M

As of 9 Sept 2024, Pharmala Biotech Holdings net assets is $1.38M, an decrease of -27.42% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the Pharmala Biotech Holdings overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.

Pharmala Biotech Holdings Net Assets History from 2021 to 2024

-
Value:-

MDMA Net Assets History by year

YearNet assetsChange
2023$1.38M-27.42%
2022$1.91M-28.21%
2021$2.66M-

View the Top Net Assets Companies

logo
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org